Johnson & Johnson Pre-Tax Income 2010-2024 | JNJ

Johnson & Johnson pre-tax income for the twelve months ending December 31, 2024 was $16.687B, a 10.79% increase year-over-year.

  • Johnson & Johnson annual pre-tax income for 2024 was $16.687B, a 10.79% increase from 2023.
  • Johnson & Johnson annual pre-tax income for 2023 was $15.062B, a 22.2% decline from 2022.
  • Johnson & Johnson annual pre-tax income for 2022 was $19.359B, a 0.94% increase from 2021.

Johnson & Johnson Pre-Tax Income 2010-2024 | JNJ

  • Johnson & Johnson annual pre-tax income for 2024 was $16.687B, a 10.79% increase from 2023.
  • Johnson & Johnson annual pre-tax income for 2023 was $15.062B, a 22.2% decline from 2022.
  • Johnson & Johnson annual pre-tax income for 2022 was $19.359B, a 0.94% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B